HSJN(SZ:002817) Sou Hu Cai Jing·2025-08-04 09:55Core Viewpoint - Huangshan Capsule's stock closed at 8.19 yuan on August 4, with a 1.74% increase, and a rolling PE ratio of 46.43, marking a new low in 373 days, with a total market value of 2.45 billion yuan [1] Company Overview - Anhui Huangshan Capsule Co., Ltd. specializes in the research, production, and sales of gelatin hollow capsules and enteric-coated gelatin hollow capsules, being one of the earliest manufacturers in China with over 30 years of high-quality production history [1] - The company has a strong reputation in the pharmaceutical hollow capsule industry and is a member of the China Pharmaceutical Packaging Association, recognized for its contributions [1] Financial Performance - In the latest quarterly report for Q1 2025, the company achieved an operating income of 119 million yuan, a year-on-year increase of 0.53%, and a net profit of 18.837 million yuan, reflecting a year-on-year growth of 22.90%, with a gross profit margin of 29.26% [2] Market Position - Huangshan Capsule's PE ratio of 46.43 is below the industry average of 54.31 and the industry median of 38.11, ranking 84th in the medical device sector [1][2] - The company’s market value stands at 2.45 billion yuan, compared to the industry average market value of 11.617 billion yuan [2] Capital Flow - On August 4, the net inflow of main funds into Huangshan Capsule was 764,500 yuan, although the overall trend over the past five days showed a net outflow of 4.3336 million yuan [1]